nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—Isoprenaline—MAPK1—melanoma	0.0107	0.466	CrCbGaD
Droxidopa—Mesalazine—PPARG—melanoma	0.00496	0.216	CrCbGaD
Droxidopa—Aminosalicylic Acid—PTGS2—melanoma	0.00267	0.116	CrCbGaD
Droxidopa—Epinephrine—TNF—melanoma	0.00254	0.111	CrCbGaD
Droxidopa—Mesalazine—PTGS2—melanoma	0.00209	0.0913	CrCbGaD
Droxidopa—ADRA1A—Signaling by GPCR—EGFR—melanoma	3.76e-05	3.84e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCL8—melanoma	3.75e-05	3.84e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTEN—melanoma	3.73e-05	3.82e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—PIK3CA—melanoma	3.73e-05	3.82e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—HRAS—melanoma	3.73e-05	3.81e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP9—melanoma	3.72e-05	3.81e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCL8—melanoma	3.72e-05	3.8e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MDM2—melanoma	3.71e-05	3.8e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CDKN1A—melanoma	3.71e-05	3.8e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—HRAS—melanoma	3.71e-05	3.8e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PTEN—melanoma	3.7e-05	3.79e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—HRAS—melanoma	3.69e-05	3.78e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NFKB1—melanoma	3.68e-05	3.77e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCL8—melanoma	3.67e-05	3.76e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—PIK3CA—melanoma	3.67e-05	3.76e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—MAPK3—melanoma	3.67e-05	3.75e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CDKN1B—melanoma	3.66e-05	3.75e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ERBB2—melanoma	3.66e-05	3.75e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MDM2—melanoma	3.66e-05	3.74e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MAP2K1—melanoma	3.65e-05	3.73e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—HRAS—melanoma	3.65e-05	3.73e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CDKN1B—melanoma	3.63e-05	3.72e-05	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AKT1—melanoma	3.62e-05	3.71e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PIK3CD—melanoma	3.62e-05	3.71e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PIK3CB—melanoma	3.61e-05	3.7e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AKT1—melanoma	3.61e-05	3.7e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ERBB2—melanoma	3.6e-05	3.69e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—BRAF—melanoma	3.6e-05	3.68e-05	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AKT1—melanoma	3.59e-05	3.68e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CASP3—melanoma	3.59e-05	3.68e-05	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—PIK3CA—melanoma	3.59e-05	3.67e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL2—melanoma	3.59e-05	3.67e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CDKN1B—melanoma	3.58e-05	3.67e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6—melanoma	3.57e-05	3.65e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CASP3—melanoma	3.56e-05	3.64e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PIK3CB—melanoma	3.56e-05	3.64e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL2—melanoma	3.55e-05	3.64e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6—melanoma	3.55e-05	3.63e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—KRAS—melanoma	3.55e-05	3.63e-05	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AKT1—melanoma	3.55e-05	3.63e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6—melanoma	3.53e-05	3.62e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CASP3—melanoma	3.51e-05	3.6e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PIK3CB—melanoma	3.51e-05	3.59e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL2—melanoma	3.51e-05	3.59e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IGF1—melanoma	3.51e-05	3.59e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCND1—melanoma	3.5e-05	3.58e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—MAPK1—melanoma	3.49e-05	3.57e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6—melanoma	3.49e-05	3.57e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—EGFR—melanoma	3.49e-05	3.57e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—melanoma	3.48e-05	3.56e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL8—melanoma	3.47e-05	3.55e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—FGF2—melanoma	3.47e-05	3.55e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCND1—melanoma	3.46e-05	3.54e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CTNNB1—melanoma	3.46e-05	3.54e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—HRAS—melanoma	3.45e-05	3.53e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CTNNB1—melanoma	3.43e-05	3.51e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCND1—melanoma	3.42e-05	3.5e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL8—melanoma	3.42e-05	3.5e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—HRAS—melanoma	3.4e-05	3.48e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP9—melanoma	3.39e-05	3.47e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CDKN1B—melanoma	3.39e-05	3.47e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MAP2K1—melanoma	3.39e-05	3.47e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CTNNB1—melanoma	3.39e-05	3.47e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CDKN1A—melanoma	3.38e-05	3.46e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PTEN—melanoma	3.37e-05	3.45e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PIK3CD—melanoma	3.37e-05	3.45e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP9—melanoma	3.36e-05	3.44e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NFKB1—melanoma	3.36e-05	3.44e-05	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AKT1—melanoma	3.35e-05	3.43e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CDKN1A—melanoma	3.35e-05	3.43e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—VEGFA—melanoma	3.34e-05	3.42e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PTEN—melanoma	3.34e-05	3.42e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CDKN1B—melanoma	3.34e-05	3.42e-05	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	3.34e-05	3.41e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NFKB1—melanoma	3.33e-05	3.4e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CASP3—melanoma	3.32e-05	3.4e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP9—melanoma	3.32e-05	3.4e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL2—melanoma	3.32e-05	3.4e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—STAT3—melanoma	3.31e-05	3.39e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CDKN1A—melanoma	3.31e-05	3.39e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NRAS—melanoma	3.3e-05	3.38e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6—melanoma	3.3e-05	3.38e-05	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AKT1—melanoma	3.3e-05	3.38e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PTEN—melanoma	3.3e-05	3.38e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—KRAS—melanoma	3.3e-05	3.37e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AKT1—melanoma	3.29e-05	3.37e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NFKB1—melanoma	3.28e-05	3.36e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AKT1—melanoma	3.28e-05	3.35e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CASP3—melanoma	3.27e-05	3.35e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL2—melanoma	3.27e-05	3.34e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AKT1—melanoma	3.26e-05	3.34e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	3.26e-05	3.34e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6—melanoma	3.25e-05	3.33e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MDM2—melanoma	3.25e-05	3.32e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCND1—melanoma	3.24e-05	3.31e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—FGF2—melanoma	3.22e-05	3.3e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AKT1—melanoma	3.22e-05	3.3e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CTNNB1—melanoma	3.2e-05	3.28e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ERBB2—melanoma	3.2e-05	3.28e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCND1—melanoma	3.18e-05	3.26e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MAPK3—melanoma	3.16e-05	3.24e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PIK3CB—melanoma	3.16e-05	3.23e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CTNNB1—melanoma	3.15e-05	3.23e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP9—melanoma	3.14e-05	3.21e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CDKN1A—melanoma	3.13e-05	3.2e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PTEN—melanoma	3.12e-05	3.2e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NFKB1—melanoma	3.11e-05	3.18e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MMP9—melanoma	3.09e-05	3.16e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CDKN1A—melanoma	3.08e-05	3.15e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MYC—melanoma	3.08e-05	3.15e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PTEN—melanoma	3.07e-05	3.15e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NFKB1—melanoma	3.06e-05	3.13e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—VEGFA—melanoma	3.05e-05	3.12e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AKT1—melanoma	3.05e-05	3.12e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL8—melanoma	3.04e-05	3.11e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTEN—melanoma	3.03e-05	3.1e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	3.03e-05	3.1e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—VEGFA—melanoma	3.02e-05	3.09e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—STAT3—melanoma	3.02e-05	3.09e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MDM2—melanoma	3.02e-05	3.09e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—HRAS—melanoma	3.02e-05	3.09e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MAPK1—melanoma	3.01e-05	3.08e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NRAS—melanoma	3.01e-05	3.08e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EGFR—melanoma	3.01e-05	3.08e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AKT1—melanoma	3e-05	3.07e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—STAT3—melanoma	2.99e-05	3.06e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NRAS—melanoma	2.98e-05	3.05e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—VEGFA—melanoma	2.98e-05	3.05e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ERBB2—melanoma	2.97e-05	3.04e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CDKN1B—melanoma	2.96e-05	3.03e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—STAT3—melanoma	2.95e-05	3.02e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NRAS—melanoma	2.94e-05	3.01e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PIK3CB—melanoma	2.94e-05	3e-05	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AKT1—melanoma	2.93e-05	3e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CASP3—melanoma	2.91e-05	2.97e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL2—melanoma	2.9e-05	2.97e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6—melanoma	2.89e-05	2.95e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MAPK3—melanoma	2.88e-05	2.95e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MAPK3—melanoma	2.86e-05	2.92e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—KRAS—melanoma	2.84e-05	2.91e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCND1—melanoma	2.83e-05	2.89e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL8—melanoma	2.82e-05	2.89e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—VEGFA—melanoma	2.82e-05	2.89e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MAPK3—melanoma	2.82e-05	2.89e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MYC—melanoma	2.8e-05	2.87e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—HRAS—melanoma	2.8e-05	2.87e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CTNNB1—melanoma	2.8e-05	2.87e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—STAT3—melanoma	2.79e-05	2.86e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NRAS—melanoma	2.79e-05	2.85e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MYC—melanoma	2.78e-05	2.84e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—VEGFA—melanoma	2.78e-05	2.84e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CDKN1B—melanoma	2.75e-05	2.82e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—STAT3—melanoma	2.75e-05	2.81e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP9—melanoma	2.75e-05	2.81e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MAPK1—melanoma	2.74e-05	2.81e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MYC—melanoma	2.74e-05	2.81e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EGFR—melanoma	2.74e-05	2.81e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NRAS—melanoma	2.74e-05	2.81e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CDKN1A—melanoma	2.74e-05	2.8e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTEN—melanoma	2.73e-05	2.79e-05	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AKT1—melanoma	2.72e-05	2.79e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MAPK1—melanoma	2.72e-05	2.78e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EGFR—melanoma	2.72e-05	2.78e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NFKB1—melanoma	2.72e-05	2.78e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CASP3—melanoma	2.7e-05	2.76e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL2—melanoma	2.7e-05	2.76e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MAPK1—melanoma	2.68e-05	2.75e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EGFR—melanoma	2.68e-05	2.75e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6—melanoma	2.68e-05	2.74e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MAPK3—melanoma	2.67e-05	2.73e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AKT1—melanoma	2.66e-05	2.73e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PIK3CA—melanoma	2.63e-05	2.7e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCND1—melanoma	2.63e-05	2.69e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MAPK3—melanoma	2.63e-05	2.69e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PIK3CA—melanoma	2.61e-05	2.67e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CTNNB1—melanoma	2.6e-05	2.66e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MYC—melanoma	2.59e-05	2.66e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—KRAS—melanoma	2.59e-05	2.65e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—KRAS—melanoma	2.57e-05	2.63e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MYC—melanoma	2.55e-05	2.61e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP9—melanoma	2.55e-05	2.61e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CDKN1A—melanoma	2.54e-05	2.6e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MAPK1—melanoma	2.54e-05	2.6e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EGFR—melanoma	2.54e-05	2.6e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTEN—melanoma	2.54e-05	2.6e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—KRAS—melanoma	2.53e-05	2.59e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TP53—melanoma	2.53e-05	2.59e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NFKB1—melanoma	2.52e-05	2.58e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MAPK1—melanoma	2.5e-05	2.56e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EGFR—melanoma	2.5e-05	2.56e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AKT1—melanoma	2.47e-05	2.53e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—VEGFA—melanoma	2.47e-05	2.52e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—STAT3—melanoma	2.44e-05	2.5e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NRAS—melanoma	2.44e-05	2.49e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—HRAS—melanoma	2.42e-05	2.47e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—KRAS—melanoma	2.4e-05	2.45e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PIK3CA—melanoma	2.38e-05	2.44e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—KRAS—melanoma	2.36e-05	2.42e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PIK3CA—melanoma	2.36e-05	2.41e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MAPK3—melanoma	2.33e-05	2.39e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PIK3CA—melanoma	2.33e-05	2.38e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6—melanoma	2.31e-05	2.37e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TP53—melanoma	2.3e-05	2.36e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—VEGFA—melanoma	2.29e-05	2.34e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TP53—melanoma	2.28e-05	2.33e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MYC—melanoma	2.27e-05	2.32e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—STAT3—melanoma	2.27e-05	2.32e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NRAS—melanoma	2.26e-05	2.32e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TP53—melanoma	2.25e-05	2.31e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MAPK1—melanoma	2.22e-05	2.27e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EGFR—melanoma	2.22e-05	2.27e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PIK3CA—melanoma	2.2e-05	2.25e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—HRAS—melanoma	2.2e-05	2.25e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—HRAS—melanoma	2.18e-05	2.23e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PIK3CA—melanoma	2.17e-05	2.22e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MAPK3—melanoma	2.17e-05	2.22e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—HRAS—melanoma	2.15e-05	2.2e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—AKT1—melanoma	2.15e-05	2.2e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PIK3CA—melanoma	2.14e-05	2.19e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AKT1—melanoma	2.13e-05	2.18e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TP53—melanoma	2.13e-05	2.18e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MYC—melanoma	2.11e-05	2.16e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6—melanoma	2.11e-05	2.16e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TP53—melanoma	2.1e-05	2.15e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—KRAS—melanoma	2.1e-05	2.15e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6—melanoma	2.09e-05	2.14e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MAPK1—melanoma	2.06e-05	2.11e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6—melanoma	2.06e-05	2.11e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EGFR—melanoma	2.06e-05	2.11e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—HRAS—melanoma	2.04e-05	2.09e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—HRAS—melanoma	2.01e-05	2.05e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6—melanoma	1.95e-05	2e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—KRAS—melanoma	1.95e-05	1.99e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AKT1—melanoma	1.94e-05	1.99e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AKT1—melanoma	1.93e-05	1.97e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PIK3CA—melanoma	1.93e-05	1.97e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6—melanoma	1.92e-05	1.96e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AKT1—melanoma	1.9e-05	1.95e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TP53—melanoma	1.86e-05	1.91e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AKT1—melanoma	1.8e-05	1.84e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PIK3CA—melanoma	1.79e-05	1.83e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—HRAS—melanoma	1.78e-05	1.82e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AKT1—melanoma	1.77e-05	1.81e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—AKT1—melanoma	1.75e-05	1.79e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TP53—melanoma	1.73e-05	1.77e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6—melanoma	1.71e-05	1.75e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—HRAS—melanoma	1.66e-05	1.69e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6—melanoma	1.58e-05	1.62e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AKT1—melanoma	1.57e-05	1.61e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AKT1—melanoma	1.46e-05	1.5e-05	CbGpPWpGaD
